Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3722_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
30 Мб
Скачать
6 Arterial Revascularization
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
87
6.1.2.1 Conclusion
Successful aortoiliac revascularization in AIOD is vital for achieving limb salvage. Familiarity with various endovascular techniques and proper execution can translate to improved clinical out­comes. Advances in endovascular technologies and improved prociency continue to provide alternatives to open surgery in TASC C and D lesions, especially in poor open surgical candidates.
6.1.3 When toConsider Aortobifemoral andFemoro­Femoral Bypass?
DanielK.Han
6.1.3.1 Aortobifemoral Bypass
Endovascular interventions for aortoiliac occlu­sive disease (AIOD) have good patency rates, and as such, the number for aortobifemoral bypasses (ABFs) that are being performed today has sub­stantially decreased, as they are a more invasive procedure with higher rates of perioperative mor­bidity and mortality.
• For patients with limited areas of disease
(short-segment iliac or aortic disease), angioplasty with stenting can lead to high technical success and long-term patency.
• Especially when considering that patients
with isolated AIOD often present with claudi­cation, an ABF that requires an open laparot­omy/retroperitoneal incision can be considered overly aggressive.
For patients with critical limb ischemia or sig­nicant life-limiting claudication, an ABF has excellent long-term patency and can provide a very durable result. In well-selected patients, ABF can have a mortality rate as low as 2% and a 10-year patency rate of around 75%.
Consideration for ABF should include the
following:
• Anatomic Considerations – Extent of Disease.
ABF should be limited to those patients with extensive AIOD. While TASC II guidelines have made suggestions for what “extensive” means, in today’s practice, several lesions that are consid­ered TASC C and D can still be effec­tively treated using endovascular options. Lesions that are challenging for endovascular intervention include the following:
• Small caliber iliac arteries.
• Extensive calcication of the iliac arteries.
• Long-segment CTO of the external iliac, common iliac, and distal aorta.
• Prior failed endovascular intervention.
• Patients with ulcerated plaques at high risk for distal embolization.
– Inow.
ABF is typically considered for patients who have a clampable portion of the infrarenal aorta. If the common iliac artery and internal iliac arteries are patent, the surgeon may consider performing an end-to-side anastomosis to maintain antegrade ow into the pelvic circulation. If the common iliac arteries or the inter­nal iliac arteries are occluded, an end­to- end anastomosis allows for better sitting of the bypass graft in the retroperitoneum.
– Outow.
The common femoral artery is the most common target for an ABF. While disease in the distal supercial femoral and popliteal arteries may be
88
I. Ali et al.
acceptable, the profunda is important for the long-term patency of the ABF.
• As such, many surgeons will perform an extended profundaplasty at the time of the distal anastomosis to ensure adequate outow.
• The ability to reconstruct a diseased profunda artery at the time of revas­cularization is another benet of ABF over endovascular interventions.
– Patient Factors.
Medical comorbidities limiting general anesthesia. Age and life expectancy. Prior abdominal surgery: The loss of normal surgical planes from prior sur­gery can lead to longer operative times and increased complication rates. Body habitus: In addition to providing technical challenges from body habitus, obese patients have signicantly increased wound complication rates. Given that most ABFs are performed using a bifurcated prosthetic conduit, an infection of the prosthetic graft can be catastrophic. Patient preference: A thorough discus­sion of risks and benets of all revascu­larization approaches should be had prior to selecting ABF as the treatment of choice.
Take Home: ABF may be the preferred revas­cularization option in good risk younger patients with extensive AIOD.
6.1.3.2 Femoro-Femoral Bypass
A fem-fem bypass is not as durable as an ABF and reported that 5-year patency rates range around 60–70%. With the increasing experience and success of endovascular revascularization for AIOD, the number of fem–fem bypasses per­formed for PAD has decreased in recent times. In fact, the most common indication for a fem–fem bypass today may be in the setting of an endovas­cular aortic aneurysm repair with an aorto-uni­iliac device.
However, the common femoral arteries are readily accessible with a surgical cutdown, and a fem–fem bypass can be performed with general, regional, or even local anesthesia. As such, a fem–fem bypass is an important option in the armamentarium of a vascular surgeon for extra­anatomic iliac artery reconstruction across many different pathologies.
Similar to the discussion above for ABF, the decision to perform a fem–fem bypass for periph­eral arterial disease must take into account the following considerations:
• Anatomic Considerations.
– A fem–fem bypass is considered for
patients with unilateral iliac artery occlu­sive disease. Similar lesions may provide a challenge for endovascular intervention:
Small caliber iliac arteries. Extensive calcication of the iliac arteries. Long-segment CTO of the external iliac and/or common iliac arteries. Prior failed endovascular intervention. Patients with ulcerated plaques at high risk of distal embolization.
• Inow and Outow.
– The success of fem–fem bypass depends
on the presence of a patent aorta and single iliac artery to serve as the inow vessel for both lower extremities and free of hemody­namically signicant lesions.
– Similarly, the donor common femoral
artery needs to be free of disease. In cases of signicant CFA disease, a con­comitant endarterectomy can be per­formed. The same holds true for the recipient CFA.
Similar to an ABF, the profunda artery is important for patency of a fem–fem bypass. In cases of signicant profunda origin disease, an extended profunda­plasty can be performed at the time of the fem–fem bypass. The impact of distal SFA disease on the patency of a fem–fem bypass is unclear in the setting of a patent profunda artery.
6 Arterial Revascularization
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
89
The nal thing to consider is that a fem–fem bypass can limit access options for future lower extremity interventions. While the bypass graft can be accessed directly, repeat access of a prosthetic bypass can lead to pseudoaneurysms or graft infection, which can lead to subopti­mal outcomes and signicant morbidity in a patient.
6.2 When toChoose Alternate
Access
6.2.1 Pedal Approach
BlakeP.Parsons and JimG.Melton
6.2.1.1 Why Choose Pedal Access
forPeripheral Arterial Intervention?
There are many benets when performing periph­eral intervention from a primary pedal approach. Benets include the following:
1. Decreased risk of bleeding/access
complications.
(a) Common femoral artery access, espe-
cially in high BMI patients, can increase the risk of bleeding complications. Tibial artery access signicantly lowers access bleeding/vascular risk. Tibial artery access can safely be performed with less than 0.5% risk of major vascular injury, similar to radial artery access.
2. Decrease in radiation exposure to you and the
patient.
(a) Tibial artery access limits the need for
increased uoroscopy time and dose over the pelvis as associated with traditional up and over access from a contralateral com­mon femoral artery approach. This can contribute to a signicant reduction in radiation dose to the patient and physi­cian. This also equates to a signicant reduction in procedure time.
3. Decrease in contrast utilization and increase
ability to cross difcult atherosclerotic lesions.
(a) There is increased ability to gain access
through difcult atherosclerotic lesions secondary to increased pushability and access of the soft cap of atherosclerotic plaque. This decreases the need for map­ping angiography. Utilization of intravas­cular ultrasound can also signicantly decrease the need for angiography. Cases can routinely be performed with less than 40cc of contrast.
Clinical Evaluation
There is no signicant change in the clinical eval­uation of peripheral arterial disease patients when comparing pedal approach for access versus tra­ditional common femoral artery access. Evaluation is still focused on a good clinical examination that is supplemented with noninva­sive vascular testing that was described in previ­ous chapters.
• However, evaluation of the tibial arteries can be difcult with noninvasive testing especially if performed by technicians who are not com­fortable with its evaluation and patients with medial calcinosis.
• Clinical evaluation with palpation of the abdominal aorta and bilateral common femo­ral arteries, supplemented with handheld Doppler interrogation of the popliteal artery, proximal and distal anterior tibial artery, prox­imal and distal dorsalis pedis artery, distal peroneal artery, and distal posterior tibial arteries (Fig.6.10) are crucial in determining arterial options for access and likely distribu­tion of patient’s disease.
• Doppler arterial examination enables not only determination of access point patency but helps determine the likelihood of a proximal lesion given the audible sound of monophasic, biphasic, or triphasic signal. All aspects of the physical examination and clinical evaluation will determine whether a primary pedal approach is appropriate.
Access
The use of ultrasound is key to successful access into the tibial arteries. Ultrasound is carefully uti-
90
I. Ali et al.
abc
Fig. 6.10 Typical location for hand help Doppler interrogation of (a) anterior tibial artery. (b) Posterior tibial artery. (c) Peroneal artery
lized to evaluate patency of both the anterior tib­ial and posterior tibial arteries.
• Upon rst becoming comfortable with pedal access, it is preferred to attempt on patients with patent two- or three-vessel runoff.
• Determining access of the tibial artery should consider the angiosome of the underlying pathology and vessel size and degree of atherosclerosis.
• Access can be performed into an occluded tibial artery with attempt to recanalize, there­fore decreasing the possibility of vascular injury and/or injury to single patent tibial artery.
• Upon becoming more comfortable with tibial artery approach, access can be gained on patients with single-vessel tibial artery runoff for the potential of increased successful revascularization.
Evaluation of the tibial artery should be per-
formed within 4–6 cm of the ankle joint (Fig. 6.11). Accessing the tibial arteries more proximally will be limited secondary to tibial artery depth/visualization.
Fig. 6.11 Access into the left anterior tibial artery with 5/4 Fr slender sheath and posterior tibial artery with 6/5 Fr sheath
ab
6 Arterial Revascularization
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
91
Fig. 6.12 (a) Ultrasound evaluation of tibial artery (solid white arrow) with paired tibial veins (open white arrows). (b) Ultrasound evaluation of tibial artery with mild com-
• There is also increased risk of bleeding with access in a more proximal location. Ultrasound evaluation demonstrates a tibial artery with a pair of tibial veins (Fig.6.12).
pression demonstrating compression of tibial veins (open white arrows) with patency of tibial artery (solid white arrow)
advanced intra-arterially with subsequent arterial runoff performed for visualization of arterial runoff below the ankle and evaluation of the pedal loop (Fig.6.13).
• There is increased success in access and decreased risk of injury with tibial arteries 2mm or larger.
• The overlying skin is anesthetized with 1%
Slender sheaths are preferred for tibial artery access. Typical sheaths utilized are thinned­walled 4/5 Fr and 5/6 Fr.
lidocaine, and ultrasound-guided access is made with direct ultrasound visualization of the needle tip intraluminal. Access using a 4cm 21-gauge micropuncture needle is pre­ferred. A 0.018 access wire should then suc­cessfully be advanced intraluminally under ultrasound and uoroscopy. Angiography can then be performed through vascular sheath or transitional dilator.
• If there is concern for small vessel disease, the inner dilator of a 3 Fr introducer sheath can be
• 6/7 Fr sheaths can be placed when needed for patients with minimal calcication and vessel diameter greater than 3.5mm.
• Braided sheaths are preferred given some issues with kinking at the access site.
• A cocktail is administered consisting of hepa­rin and nitroglycerin.
– Typical cocktail administered includes
3000units heparin and 200 mcg nitroglyc­erin through the indwelling sheath.
92
Fig. 6.13 Digital subtraction angiography of left foot performed through posterior tibial artery access and placement of the inner dilator of 3F access sheath
– Heparin is then dosed through peripheral
IV on a weight-based scale per the per­forming physician.
6.2.1.2 Primary Pedal Intervention
Upon review of patient’s physical examination and retrograde angiogram, physician should have a good idea of the disease location.
• If intervention will likely be warranted in the aortoiliac distribution or femoral–popliteal distribution, a 5/6 Fr thin-walled sheath should be utilized.
• If patient’s disease is small vessel and involv­ing primarily a tibial artery distribution, inter­vention can be performed through a 4/5 Fr thin-walled sheath. Upon evaluation from a retrograde angiogram from your tibial artery access, guidewires and crossing catheters are advanced centrally. Typical working wires are
I. Ali et al.
similar to wires utilized in a standard ante­grade fashion.
A primary pedal approach can routinely be utilized for interventions of the iliac arteries, supercial femoral artery/popliteal artery, and tibial arteries. By using a primary pedal approach, multilevel arterial inventions can be performed in a single intervention.
• Once retrograde angiography and evaluation
of the tibial arteries have been performed, a
0.014 or 0.018 guidewire is typically
advanced centrally.
• If chronic total occlusion is demonstrated
along the femoral–popliteal or iliac artery
distribution, standard crossing techniques
can be utilized as from an antegrade
approach.
• A 0.035 catheter can be advanced into the
distal abdominal aorta to allow pelvic angiog-
raphy. The catheter can then be retracted into
the iliac arteries with angiography of the
intended leg and visualization of peripheral
arterial disease.
• The use of intravascular ultrasound is highly
recommended for evaluation of plaque mor-
phology, subintimal versus intraluminal loca-
tion, dissection, and precise intervention to
disease segments only.
– By utilizing intravascular ultrasound, this
will signicantly decrease your total con­trast utilization and radiation exposure to you and the patient.
Re-entry devices such as Pioneer (Philips) and Outback (Medtronic) can be used from a retro­grade approach. All atherectomy devices that accommodate a 6 Fr vascular sheath can be uti­lized. These include rotational, orbital, direc­tional, and laser and lithotripsy options. If stent placement is warranted within the femoral–popli­teal territory, all intra-arterial stents that accom­modate a 6 Fr vascular sheath can be utilized.
• By coming from a retropedal approach, pre-
cise SFA stent placement at the femoral bifur-
cation can be easily accomplished, minimizing
6 Arterial Revascularization
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
93
risk of compromise to the profunda femoris artery.
• Stents will need to be placed from proximal to distal fashion so that there is no risk of passing a secondary stent through an initial stent caus­ing stent migration and/or inability to advance the secondary stent centrally.
• If iliac artery intervention is warranted it should be performed initially, prior to inter­vention in the femoral/popliteal or tibial arte­rial territory. Iliac artery intervention can be safely performed from a tibial artery access.
However, all precautions and preparation
should be taken if urgent femoral artery access is needed and/or cover stent placement is warranted for underlying vascular injury.
• The largest balloon-expandable stent that can be deployed through a 6 Fr sheath is a 9mm x 28mm Herculink (Abbott). However, 8mm balloon-expandable stents are routinely uti­lized and can be overdistended to 9mm when warranted.
• If iliac arteries are larger in size warranting larger stent sizes, then common femoral artery access may be warranted in a staged fashion.
• External iliac artery disease can be easily treated with self-expanding nitinol stents up to 12 mm through a 6 Fr vascular sheath. Angioplasty balloons on 0.018 platforms such as Sterling (Boston Scientic) will allow you utilize up to 10mm diameter balloon through a 6 Fr sheath.
• Angioplasty balloons on 0.035 platforms will allow treatment up to 12mm through a 6 Fr vascular sheath. However, removal of larger balloons can be tight through tibial arteries and 5/6 Fr thin-walled sheaths.
Interventions on the tibial arteries and the
pedal loop can be performed from a retropedal approach.
• An up and over-approach can be utilized from the anterior tibial artery into the peroneal artery or posterior tibial artery and posterior
tibial artery access into the anterior tibial artery.
• A modied 4 Fr SOS Omni Select catheter or 90-degree Berenstein (Fig.6.14) can be used to easily cannulate the intended tibial artery.
• 0.018 and 0.014 microwires are preferred for below-knee tibial artery intervention.
• 90 cm crossing catheters such as Rubicon (Boston Scientic) or Quick-Cross (Philips) can be used to provide ample support and gain access through dense calcication within the distal tibial arteries and into the forefoot/pedal loop.
• Atherectomy devices, such as Rotablator (Boston Scientic), Excimer Laser (Phillips),
1.5 mm Phoenix (Philips), and Orbital Diamondback (CSI) can be used in the tibial arteries from up and over-approach. Angioplasty is performed from 0.014 and
0.018 balloon platforms, and 90 cm length balloon shafts are preferred for ease of use. Tibial artery stent placement can be performed if warranted with a variety of coronary and dedicated peripheral arterial stents.
Postoperative Care
If there is concern for arterial spasm, nitroglyc­erin can be administered prior to removal of the tibial artery sheath.
• The vascular sheath should be removed with relative light to moderate traction. Hemostasis can be achieved using manual pressure and or banding.
• While pressure is being applied to the access site, periodic interrogation with handheld arte­rial Doppler is recommended on the distal tibial arteries in comparison with preoperative evaluation.
• Manual pressure is typically performed for 15–20min. One of the postoperative benets of tibial artery access is that the patient can immediately sit up in postoperative recovery and eat and drink once appropriately recov­ered from sedation.
• After hemostasis has been achieved, the patient will be evaluated for 20min followed by the patient being positioned on the edge of
94
ab
cd
I. Ali et al.
Fig. 6.14 (a) 4 Fr SOS Omni Select catheter. (b) Modied 4 Fr SOS Omni Select catheter with cut made at descending portion. (c) 4 Fr 90° Berenstein catheter (d)
the bed with leg in a dependent position for another 20 min. If there is no concern for bleeding/hematoma, the patient is then walked to ensure adequate hemostasis prior to discharge.
Modied 4 Fr 90° Berenstein catheter with cut made 1–2mm from distal tip
tine common femoral artery access procedures. During follow-up clinical visitation, the tibial arteries, specically the access artery, should be evaluated with handheld arterial Doppler distal to site of access to ensure patency. Arterial duplex ultrasound can also be performed if
Postoperative care with antiplatelet therapy
needed.
and clinical evaluation is unchanged from rou-
6 Arterial Revascularization
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
95
Postoperative Complications
Inability to remove a tibial artery access sheath secondary to arterial spasm is extremely rare. However, administration of nitroglycerin and/or verapamil through the tibial artery sheath and topical nitroglycerin can be performed with light continuous manual traction.
• If access into a single tibial artery runoff was performed, there may be issues with vasospasm/small periarterial hematoma and decreased perfusion to the foot.
• Typically, this will resolve without any inter­vention over the next 10–15min as vasospasm resolves.
• If there is continued concern, topical nitro­glycerin paste can be placed over the access artery and placing the lower leg and foot in a warm blanket.
• If ischemia persists and there is concern for further damage, repeat angiography from an antegrade approach and potential angioplasty across the access site may be warranted.
Approximately 30% of patients will have
some mild postoperative soreness within the area of access, which will typically resolve over the next 3–4days.
• Postoperative pain is most commonly second­ary to small hematoma formation along the neurovascular bundle. The risk of major vas­cular injury is less than 1%.
6.2.1.3 Use ofExtra-Vascular
Ultrasound (EVUS) forPedal Access andGuiding Therapy
AbigailMize, JihadA.Mustapha, and FadiA.Saab
The use of ultrasound has historically been used for diagnostic evaluation of arterial disease in the lower extremities, in addition to a multitude of other diseases throughout the body. Implementation of the modality for interven­tional procedures to directly visualize vascular structures provides additional safety and infor­mation to promote better outcomes for patients
with cardiac and vascular disease. To standardize the approach of treating chronic total occlusions (CTO), we will describe multiple techniques for the utilization of ultrasound within the interven­tional suite, referred to as extra-vascular ultra­sound (EVUS). EVUS is used for safe access of tibial arteries, crossing CTOs, treating lesions, and placing devices within vessels. These tech­niques require good understanding of how the vessels and devices appear under ultrasound. This section focuses on the use of EVUS to dene CTO parameters and how to utilize EVUS to aid in crossing these lesions.
Introduction
The use of ultrasound for interventional proce­dures was a natural evolution of the current tech­nology and has been established as a time-honored tool that decreases rates of complication and increases accuracy [2226].
• Patients with CLI can require an average of
1.9–2.4 procedures each to achieve complete revascularization [27]. All these factors expose patients to higher rates of complications that may offset the benet achieved from revascularization.
• Utilization of ultrasound to obtain femoral access for revascularization procedures has been shown to decrease the rate of complica­tions and improve accuracy [26]. Due to dis­ease complexity and comorbidities surrounding CLI patients, the next step in ultrasound utilization is to incorporate it into treatment strategy.
• The term extra-vascular ultrasound (EVUS) refers to the use of transcutaneous ultrasound imaging to visualize vascular structures and equipment during the interventional proce­dure. The modality provides live feedback for the operator to plan and adjust their treatment plan.
This chapter will provide the vascular inter-
ventionalist with essential information required to incorporate EVUS into their practice. Terms described here are new and reect the novelty of the concept. The authors believe the utilization of
96
I. Ali et al.
EVUS in revascularization of patients with CLI and PVD will be essential as our patient popula­tion becomes older and more complex.
Ultrasonic Features ofArteries
To understand how to use EVUS to deliver ther­apy, the operator must develop a clear under­standing of how these vessels appear under ultrasound. Traditionally, interventionalists depend on angiography to dene the vascular lumen. This has pushed a lot of operators to describe imaging obtained via angiography as “luminograms,” meaning the contrast denes the inner borders of the lumen. Depending on the location of the structure of interest, different probes with different frequencies are utilized to obtain the best image resolution possible.
• Larger vessels with greater than 3cm depth, such as common femoral, supercial femoral, and popliteal arteries, are imaged with a stan­dard vascular linear ultrasound probe, with frequencies ranging from 9 to 12MHz.
• Smaller supercial arteries, such distal tibial and pedal arteries, are imaged with a higher resolution vascular ultrasound probe, some­times referred to as a “hockey stick” probe, with frequencies ranging from 15 to 20MHz. Varying frequencies of the ultrasound probes depend on system manufacturer.
Ultrasound images are displayed on the screen
based on how quickly sound waves reect off structures and return to the probe. Soft or uid-
lled structures display as dark or black on the screen with more dense or calcied structures displayed as bright white [28]. This concept directly correlates to the visualization of the artery wall layers on EVUS.
• The intimal layer of the artery is comprised of the endothelial lining of the inner lumen and appears as a thin bright white line on EVUS.
• The medial layer is made up of smooth muscle cells with heavy blood saturation, creating a dark echolucent appearance.
• The collagenous adventitia appears as a mixed echogenic outer later just beyond the dark adventitia.
• Lower extremity arteries can have plaque for­mation across the three vascular layers, and EVUS can be used to clearly dene plaque position to inuence treatment decision­making and device placement (Fig.6.15).
EVUS forPedal Access
When utilizing EVUS for tibial artery access, the vessels can be identied in a short-axis (trans­verse) view. The distal posterior tibial artery is best identied just posterior to the medial malle­olus and the anterior tibial artery is best identied in the top of the ankle. Choosing the best access point depends on the location of treatment required.
• Tibial access should be obtained in the distal third of the calf, approximately 3–4 nger
a b
Fig. 6.15 (a, b) Long- and short-axis extra-vascular ultrasound (EVUS) image of a tibial artery with denition of all three arterial walls